益气活血化瘀法联合无创辅助通气治疗慢阻肺急性加重期呼吸衰竭的临床分析  

Clinical efficacy of the Yiqi Huoxue Huayu therapy plus NIPPV on respiratory failure from AECOPD

作　　者：陆敬宪 鲍林林 

机构地区：[1]江苏省宿迁市中医院,江苏宿迁223800

出　　处：《中医临床研究》2017年第29期32-34,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究慢阻肺急性加重期呼吸衰竭临床治疗中益气活血化瘀法联合无创辅助通气治疗的应用情况。方法:选择我院2013年1月-2016年8月收治的46例慢阻肺急性加重期呼吸衰竭患者,根据临床治疗方法的不同分为对照组和观察组,观察比较两组患者临床症状改善情况、血气分析及治疗效果。结果:1个疗程治疗后,两组患者症候积分均得到不同程度改善,观察组治疗后症候积分为(3.17±2.80)分,显著低于对照组(P<0.05);两组患者在治疗3d和7d后血气分析Pa O2及Pa CO2指标存在显著性差异(P<0.05),p H无明显差异(P>0.05);对照组治疗总有效率为82.61%,观察组为95.65%,观察组总有效率显著高于对照组(P<0.05)。结论:益气活血化瘀法联合无创辅助通气治疗慢阻肺急性加重期呼吸衰竭疗效确切,可有效促进患者呼吸,充分发挥中西医联合治疗优势改善呼吸系统,短期治疗效果显著,安全性高。Objective:To explore efficacy of the Yiqi Huoxue Huayu therapy plus NIPPV on respiratory failure form AECOPD.Methods:46patients were divided into the control group and observation group.The clinical symptoms in two groups were observed and compared.Results:After a course,the scores in two groups were improved.The score in the observation group was(3.17±2.80),significantly lower than that in the control group(P<0.05).PaO2and PaCO2showed differences between two groups in3days and7days(P<0.05).There was no significant difference of pH between two groups(P<0.05).The total efficiency was82.61%in the control group,and lower than95.65%in the observation group(P<0.05).Conclusion:The Yiqi Huoxue Huayu therapy plus NIPPV on respiratory failure form AECOPD is effective,by effectively promoting breathing and the respiratory system,with good short efficacy and safety.

关 键 词：益气活血化瘀法 无创辅助通气 慢阻肺 加重期呼吸衰竭 治疗效果 

分 类 号：R563.8[医药卫生—呼吸系统]